Verified
Amgen
Pharmaceuticals
Founded: Not Available
Headquarters: 1 Amgen Center Dr, Thousand Oaks, California, 91320, United States
Overview
Location
California, United States
Headquarter
1 Amgen Center Dr, Thousand Oaks, California, 91320, United States
Contact Number
(805) 447-1000
No of Employees
25,200 Employees
Industry
Pharmaceuticals
Contact Email
Not Available
Company Type
Public Company
Website
Founded
Not Available
CEO
Not Available
Codes
SIC Code 28,283 | NAICS Code 32,325
Annual Revenue
$33.4 Billion
Total Funding
$2B
Recent Funding Amount
$2B
No of Funding Rounds
2
Company Overview
Amgen harnesses the best of biology and technology to fight the worlds toughest diseases, and make peoples lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond whats known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
Employees by Level
C-Level
7
VP-Level
377
Director
4057
Manager
9362
Non-Manager
14430
Top Contacts
25841
Top C-suite Members of Company
Connect with key decision-makers at Amgen. View contact details of C-suite executives and leadership team.
| Name | Title | Contact | |
|---|---|---|---|
| Peter Griffith | Executive VP & Chief Financial Officer | p****h@amgen.com | |
| David Reese | Executive VP & Chief Technology Officer | d****e@amgen.com | |
| David Reese | Executive VP, Research & Development | d****e@amgen.com | |
| Esteban Santos | Executive VP, Operations | e****s@amgen.com | |
| Sharlease Collier | Interim Chief of Staff | s****r@amgen.com | |
| Robert Brenner | Chief Medical Officer | r****r@amgen.com | |
| Tiffany Williams | Controller | t****s@amgen.com | |
| Beatriz Leal | Finance & Tax Compliance Controller (Mexico, | b****l@amgen.com | |
| Tiffany Williams | Controller | t****s@amgen.com | |
| Meghanne Downes | Deputy Chief Compliance Officer, Rare Disease | m****s@amgen.com | |
| Katherine Rizos | Director, Strategic Planning & Operations & T | k****s@amgen.com | |
| Perry Goldman | Vice President & Deputy General Counsel | p****n@amgen.com | |
| Wes Blumenshine | General Counsel | w****e@amgen.com | |
| David Reese | Executive VP & Chief Technology Officer | d****e@amgen.com |
Employees Contact
Are you Seeking to connect with decision-makers? Acquire their contact info, including emails and phone numbers, from credible sources like LinkedIn or trusted websites.
| Name | Position | Phone | Profile | |
|---|---|---|---|---|
Anna Richo | Chief Administrative Officer | ******1000 | a.......o@ucb.com | |
Diane Parks | Sales Nephrology Us | ******2867 | d.......s@pharmacyclics.com | |
John Kinney | Commercial Delivery Innovation | *******5052 | k.......j@amgen.com | |
Siobhan Nolan | Development Operations | ******1000 | s.......n@amgen.com | |
Suzie Briffa | Administrative | ******1000 | s.......a@amgen.com | |
Holly Brunbeck | Engineering Projects Capital Projects Management | ******8730 | h.......b@amgen.com | |
Gordon Schiff | Seattle, Washington A Okolã , Usa | ******0430 | s.......g@immunex.com | |
Aruna Jeans | Medical Communications | ******1000 | a.......s@amgen.com | |
Orlando Campos | Supply Chain | ******1000 | o.......s@amgen.com | |
Deirdre Kuzela | Compliance | ******1000 | d.......a@amgen.com | |
Robyn Barbary | Medical Education Oncology | ******1000 | r.......y@amgen.com | |
Sandra Warwick | Regulatory Affairs | ******1000 | s.......k@amgen.com | |
Kathleen Miller-williams | Corporate Quality | ******1998 | k.......r@amgen.com | |
Jim Duliakas | Is Programmer | ******1000 | d.......s@amgen.com | |
Shishir Dube | Project Data Scientist Business | ******1825 | s.......e@gmail.com | |
James Copeman | Medical Information | ******3343 | j.......n@amgen.com | |
John Jarrett | Oncology Extramural Research | ******1000 | j.......t@amgen.com | |
Rajat Sapra | Marketing | ******1000 | r.......a@amgen.com | |
Pamela Brown | Process Scientist | ******2112 | p.......n@redwood.com | |
Renee Lambert | Hr Ops | ******6312 | r.......t@yahoo.com | |
Tina Saladino | Administrative Coordinator Biosimilars Global | *******0552 | s.......o@amgen.com | |
Mingyue Zhou | Scientist | *******2000 | m.......u@amgen.com | |
Cesar Libanati | Clinical Research Medical | ******2326 | c.......l@amgen.com | |
Sterling Miller | Directory | ******3100 | m.......1@amgen.com | |
Elaine Yim | Medical Information | ******3401 | e.......m@amgen.com | |
Chad Mccormack | Systems | ******1000 | c.......a@amgen.com | |
John Wang | Business Analysis Info | ******2518 | z.......g@yahoo.com | |
Annamarie Lee | Contracts Pricing | ******6502 | a.......e@cumberlandcg.com | |
Jim Daly | It Administration | ******1000 | j.......4@gmail.com | |
Maria Wik | Scientist | ******1000 | m.......k@amgen.com | |
Allison Mcinerney | Regulatory Promotion Material Compliance | ******1000 | a.......y@amgen.com | |
Mike Sullivan | Marketing | *******5412 | m.......v@amgen.com | |
Alain Cardinal | Data Integration | ******6797 | a.......l@amgen.com | |
Bob Edson | Sole Proprietor | ******1000 | e.......1@gmail.com | |
Heather Bunyard | Commercial Information Management | ******1636 | h.......d@amgen.com | |
Annika Ohlsson | Regulatory Affairs Compliance | ******1000 | a.......n@amgen.com | |
Delia Kish | Business Operations Information Systems | *******3436 | d.......h@amgen.com | |
Susan Shetterly | Scientist | ******2536 | s.......r@amgen.com | |
Lionel Aguayo | Supply Chain | ******6279 | l.......o@amgen.com | |
Kelly Laiewski | Supply Chain | ******1000 | g.......5@verizon.net | |
David Bridges | Oncology District | ******1000 | d.......s@amgen.com | |
Peter Ilnitzki | Manufacturing Engineering | ******1200 | p.......i@amgen.com | |
Elaine Rothermel | Quality Assurance | ******1413 | e.......l@amgen.com | |
James Sesic | Regulatory Cmc | ******2818 | j.......c@amgen.com | |
Cynthia O'malley | Observational Research | ******1000 | c.......y@amgen.com | |
Renee Delagardie | Application Support | ******1000 | r.......d@amgen.com | |
Christina Ahmad | Product Inflammation | ******5866 | c.......d@amgen.com | |
Jorge Arellano | Pricing Payer Planning Oncology | ******1446 | j.......o@amgen.com | |
Christian Schwarz | Quality Engineer | ******6053 | c.......z@amgen.com | |
Paul Blalock | Contract Manufacturing | ******1000 | p.......k@amgen.com | |
Janet Morales | Talent Solution | *******5654 | j.......s@amgen.com | |
Thomas Gleason | Scientist | ******1432 | t.......n@amgen.com | |
Thu Dang | Scientist | ******5535 | t.......d@amgen.com | |
Gunjan Sharma | Marketing | ******1000 | g.......a@amgen.com | |
Eskouhie Tchaparian | Scientist Dmpk | ******4330 | e.......e@amgen.com | |
Carlyn Crisostomo | Strategy Innovation Technology Innovation | ******4759 | c.......o@gmail.com | |
Stefan Sonderhoff | Scientist | ******1000 | s.......h@amgen.com | |
Tom Guinn | Marketing | ******7713 | t.......n@ametek.com | |
Thomas Mcnerney | Scientist | ******7637 | m.......t@amgen.com | |
Barbara Burgess | Hr | ******5488 | b.......s@amgen.com | |
Patricia Stanley | Program Management | ******2578 | p.......y@onyx-pharm.com | |
James Gould | Clinical Data Management | ******5253 | j.......d@yahoo.com | |
Bethany Mancilla | Transactions | ******1000 | b.......a@amgen.com | |
Alex Watters | Staff Scientist | ******2000 | a.......4@yahoo.com | |
Jeff Andresen | Hematology Oncology Research | ******1000 | j.......n@gmail.com | |
Kipp Snider | Board Directors | ******7192 | k.......r@amgen.com | |
Susan Simons | Product Business Process Operations Planning | ******1000 | s.......1@hotmail.com | |
Daniel Campanha | Cio; | ******1000 | c.......a@amgen.com | |
Katherine Bell | Training Development | ******2647 | k.......l@amgen.com | |
Alan Ryan | Litigation | ******8860 | a.......n@amgen.com | |
Reannon Rieder | Quality Control | ******7106 | r.......r@comcast.net | |
Jennifer Sampson | Clinical Research Study | ******1000 | j.......n@amgen.com | |
Joe Naemura | Scientist | ******7000 | j.......a@amgen.com | |
Bryan Lemon | Dr | ******2224 | b.......d@yahoo.com | |
Veena Dhir | Clinical Research Study | ******1000 | v.......r@amgen.com | |
Daniel Sturm | Medical Information | ******5933 | s.......d@amgen.com | |
Wendy Acton | Business Partner Hr | ******1000 | w.......n@amgen.com | |
Tom Flanagan | Chief Information Officer | ******1000 | f.......t@amgen.com | |
Paul Byrne | Maintenance | ******1000 | p.......e@amgen.com | |
Isaiah Dimery | Safety Medical | *******1020 | i.......y@amgen.com | |
Charlotte Kyne | Clinical Research Study | ******1000 | c.......y@amgen.com | |
Daniel Sowa | Biosimilars Strategy Marketing | ******1000 | d.......a@amgen.com | |
Andrea Robinson-smith | Clinical Data Management | ********6267 | a.......h@astrazeneca.com | |
Robin Kouyate | Behavior Design Amgen Digital Health | ******1000 | r.......e@amgen.com | |
Brigitte Walker | Benefits | ******0123 | b.......r@amgen.com | |
Tae Lee | Chief Scientist | ******1000 | t.......l@amgen.com | |
Katja Björklöf | Medical Communications Oncology | ******1000 | k.......f@amgen.com | |
Chris Derespino | Business Development | ******1000 | c.......o@amgen.com | |
Angela Bevan | Administrative | ******9586 | a.......1@gmail.com | |
Beth Williston | Quality | ******2664 | b.......n@comcast.net | |
Mayellen Banister | Information Technology Finance Department | ******1000 | b.......r@amgen.com | |
Deborah Cromwell | Cw Jll Project | ******0238 | c.......l@amgen.com | |
Chuck Li | Automation Technology | ******1000 | c.......i@amgen.com | |
Nicholas Razum | Information Systems Security | ******0281 | n.......m@amgen.com | |
Michael Laverty | Information Systems Amgen Inc. | ******1000 | m.......y@amgen.com | |
Deirdre Dickey | Seeking New Opportunities As Project Business | ******1000 | d.......s@amgen.com | |
Steve Arvedson | Research Operations | ******1000 | s.......a@amgen.com | |
Benjamin Goldfarb | Strategy Commercialization Innovation | ******1000 | b.......n@altuse.com | |
Tina Stewart | Clinical Research Study | ******1000 | s.......t@amgen.com | |
Chris Vezina | Assoc Scientist | ***********1051 | c.......a@amgen.com |
Email Formats
Discover the email patterns used at Amgen to connect with the right people.
The predominant email format at Amgen is first initials + last (e.g., jdoe@amgen.com), utilized by 40.83% of all professional email addresses at the organization.
| Email Format | Example | Percentage |
|---|---|---|
| first initials + last | jdoe@amgen.com | 40.83% |
| first.last | jon.doe@amgen.com | 30.75% |
| first initials + last initials | jdoe@amgen.com | 12.90% |
| first + last initials | jons@amgen.com | 11.55% |
| first + last | jondoe@amgen.com | 4.15% |
Email Verification Tool
Get verified email addresses of any IBM employee. Enjoy 100 free lookups every month.
Enter a person's name or an email address to verify
Frequently Asked Questions
What is the address of Amgen's headquarters?
Amgen is headquartered at 1 Amgen Center Dr, Thousand Oaks, California, 91320, United States.
How can I contact Amgen by phone?
You can reach Amgen by calling their customer support number at (805) 447-1000.
Which stock symbol does Amgen trade under?
The stock ticker for Amgen is AMGN.
What is the official website for Amgen?
You can visit Amgen's official website at www.amgen.com.
How much revenue does Amgen generate?
Amgen reports an annual revenue of approximately $33.4 Billion.
What is the SIC code for Amgen?
The Standard Industrial Classification (SIC) code for Amgen is 28,283.
What is the NAICS code for Amgen?
Amgen falls under the NAICS code 32,325.
How many people work at Amgen?
Amgen has a workforce of about 25,200 employees.
Which industry is Amgen part of?
Amgen operates in the Pharmaceuticals, Healthcare industry.
Which technologies are used by Amgen?
Amgen utilizes technologies like Solidworks, DataWeave, Microsoft IIS, Angular 4.
Who is the Chief Executive Officer (CEO) of Amgen?
The CEO of Amgen is .
How can I get in touch with Amgen?
To contact Amgen, call (805) 447-1000 or visit their website at www.amgen.com
Is Amgen a publicly traded company?
Yes, Amgen is publicly listed and trades under the stock symbol AMGN.
How much total funding has Amgen secured so far?
To date, Amgen has raised $2B across 2 funding round(s).
Who are the main competitors of Amgen?
Key competitors of Amgen include GILEAD SCIENCES, Genentech, Regeneron Pharmaceuticals, Bristol-Myers Squibb
Which companies has Amgen acquired?
Acquisitions by Amgen include ChemoCentryx, KAI Pharmaceuticals, Five Prime Therapeutics, Tularik .
Who holds the CFO position at Amgen?
Peter Griffith serves as the Chief Financial Officer (CFO) at Amgen.
Who is the Chief Technology Officer (CTO) at Amgen?
David Reese is the Chief Technology Officer (CTO) at Amgen.
When did Amgen complete its most recent funding round?
Amgen latest funding round closed on Dec 23, 2022 with the amount of $2 Billion
Generate quality leads for your business
Connect with anyone who has a LinkedIn URL, regardless of their
industry, department, company, or country.
Free Credits to claim
No credit card needed
Instant leads result